1. Catalogs
  2. NexusDx
  3. IB10 sphingotest® NT-proBNP

IB10 sphingotest® NT-proBNP

IB10 sphingotest® NT-proBNP
1 / 65 PagesView full catalog

IB10 sphingotest® NT-proBNP

Product catalog summary
Introduction and Purpose: The IB10 sphingotest® NT-proBNP is a rapid in vitro diagnostic test designed for the quantitative determination of NT-proBNP in human whole blood or plasma. It is intended for professional use in hospital laboratories and healthcare facilities to aid in diagnosing and managing congestive heart failure (CHF).
Product Overview: This test measures NT-proBNP levels using EDTA or lithium heparin as anticoagulants, providing results in 20 minutes with the Nexus IB10 Analyzer. It is crucial for diagnosing CHF, a condition affecting millions in the US.
Test Principle: The test employs immunochemistry combined with microfluidics and centrifugal flow to prepare plasma from whole blood. The plasma is then mixed with immunoconjugates for quantitative measurement, with results displayed by the Nexus IB10 Analyzer.
Reagents and Materials: The test kit includes biotin-conjugated polyclonal anti-NT-proBNP antibody, dye-conjugated monoclonal anti-NT-proBNP antibody, and streptavidin. Additional equipment required includes the Nexus IB10 Analyzer and external quality control materials.
Precautions and Warnings: The test is for in vitro diagnostic use only. Proper handling and disposal of samples and test materials are essential to prevent contamination and infection risks. Ensure the analyzer software is updated and do not use damaged or expired tests.
Storage and Stability: Store test discs between 2°C and 8°C. They remain stable at 18°C to 30°C for 30 days if unopened and not exceeding the expiration date.
Sample Collection and Preparation: Use EDTA or lithium heparin whole blood or plasma. Test whole blood within 24 hours of collection, while plasma samples can be frozen for longer storage.
Procedure: Follow the Nexus IB10 Analyzer User Manual for installation and operation. Perform system checks and disc calibration before testing. Use external controls to ensure test performance.
Interpretation of Results: NT-proBNP concentration range is 30 to 5,000 pg/mL. Decision thresholds are 125 pg/mL for patients under 75 and 450 pg/mL for those 75 and older. Results above these thresholds suggest CHF.
Quality Control: Use external controls to confirm test performance. The test includes an internal control to validate results.
Limitations: Results should be used with other clinical information. Differences exist between lithium heparin and EDTA samples, and they should not be used interchangeably. Interference from other substances or procedural errors can affect results.
Performance Characteristics: The test measures NT-proBNP levels from 30 pg/mL to 5,000 pg/mL with a Limit of Detection (LoD) of 30 pg/mL and a Limit of Quantitation (LoQ) of 50 pg/mL. No significant interference was observed from common drugs or endogenous substances. Precision was determined with within-run and total coefficients of variation (CVs) computed according to CLSI guidelines.
Comparison Studies: A comparison with the Roche Elecsys® proBNP II assay showed a high correlation, confirming the test's reliability.
See more

Catalog excerpts

IB10 sphingotest® NT-proBNP-1

For the Quantitative Determination of NT-proBNP in EDTA and Lithium Heparin Human Whole Blood and Plasma

 Open the catalog to page 1
IB10 sphingotest® NT-proBNP-2

IB10 sphingotest® NT-proBNP For In Vitro Diagnostic Use INTENDED USE The IB10 sphingotest® NT-proBNP is a rapid test for the in vitro quantitative determination of N-terminal pro-brain natriuretic peptide (NT-proBNP) in human whole blood or plasma using EDTA or lithium heparin as the anticoagulant. The NT-proBNP Test is intended for use in conjunction with the Nexus IB10 Analyzer and provides quantitative results in 20 minutes. This Test is designed for professional use only and may be used in hospital central laboratories and in alternate care settings such as emergency departments, critical...

 Open the catalog to page 2
IB10 sphingotest® NT-proBNP-3

• For in vitro diagnostic use only. • Carefully follow the Instructions for Use. • Prior to testing controls or patient samples, ensure that the Analyzer software is updated to the latest version. Refer to the Nexus IB10 manual for specific instructions. • Wear disposable gloves while handling samples. • Handle samples with care. Samples and used Test discs should be treated as if potentially infectious and should be discarded as biohazardous materials according to local regulations. • Thoroughly wash hands following handling. • The result obtained from the IB10 sphingotest® NT-proBNP does not...

 Open the catalog to page 3
IB10 sphingotest® NT-proBNP-4

RUNNING QC WITH EXTERNAL CONTROLS The manufacturer recommends the use of commercially available NT-proBNP Controls (please refer to section Materials/Equipment Required But Not Provided). Ensure that the NT-proBNP controls are handled and prepared according to the corresponding Instructions for Use (IFU). 1. Remove an unopened pouch from refrigeration and place it at room temperature (19 to 25 °C/66 to 77 °F) for at least 15 minutes prior to testing. 2. Open the pouch and remove the Test disc. 3. Place the Test disc on a level surface. 4. On the Nexus IB10 Analyzer press New Analysis. 5. The...

 Open the catalog to page 4
IB10 sphingotest® NT-proBNP-5

INTERPRETATION OF RESULTS The range of NT-proBNP concentration reported by the Nexus IB10 Analyzer is 30 pg/mL to 5,000 pg/mL. Results below or above this range will be shown as “< 30 pg/mL” or “> 5,000 pg/mL,” respectively. • Recommended Decision Threshold Values: • Patients under 75 years of age: 125 pg/mL • Patients 75 years of age and older: 450 pg/mL • NT-proBNP results less than or equal to the decision threshold values are considered normal values, representative of patients without CHF. • Results greater than the recommended decision threshold values are considered abnormal and are suggestive...

 Open the catalog to page 5
IB10 sphingotest® NT-proBNP-6

The following drugs were tested for potential interference in the IB10 sphingotest® NT-proBNP (Table 1). The list of drugs encompasses common prescription and over-the-counter medications, as well as those often prescribed in a cardiac patient population. The drugs were tested at concentrations as recommended in the CLSI Approved Guideline EP7-A2 'Interference Testing in Clinical Chemistry, '13 or at least three times the highest concentration reported following a therapeutic dose. No significant interference with the IB10 sphingotest® NT-proBNP was observed for the drugs listed in the table...

 Open the catalog to page 6
IB10 sphingotest® NT-proBNP-7

HOOK EFFECT No high dose Hook Effect was observed for NT-proBNP concentrations up to 300,000 pg/mL. The precision of IB10 sphingotest® NT-proBNP was determined using samples where recombinant NT-proBNP was added to normal human plasma at three concentrations (Table 3). The within-run and total precision was performed in two runs per day, in replicates of 5 per run at each concentration level for a 20 day period for a total number of repetitions of 200 at each concentration level. The within-run and total coefficients of variation (CVs) were computed according to CLSI guideline EP05-A3.14 WHOLE...

 Open the catalog to page 7
IB10 sphingotest® NT-proBNP-8

9. Cowie MR, Jourdain P, Maisel A, et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 2003;24:1710-18. 10. Mair J, Hammerer-Lercher A, Puschendorf B. The Impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001;39:571-88. 11. McDonagh TA, Holmer S, Raymond I, et al. NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. Eur J Heart Fail 2004;6:269-73. 12. Pierson-Perry J, Vaks JE, Durham AP, et al. Evaluation of detection capability for clinical...

 Open the catalog to page 8
IB10 sphingotest® NT-proBNP-9

Fur die quantitative Bestimmung von NT-proBNP in EDTA und Lithiumheparin von humanem Vollblut und Plasma

 Open the catalog to page 9
IB10 sphingotest® NT-proBNP-10

IB10 sphingotest® NT-proBNP Zum Gebrauch als In-vitro-Diagnostikum VERWENDUNGSZWECK Der IB10 sphingotest® NT-proBNP ist ein Schnelltest für die quantitative In-vitro-Bestimmung von N-terminalem pro-brain natriuretischem Peptid (NT-proBNP) in humanem Vollblut oder Plasma mithilfe von EDTA oder Lithiumheparin als Antikoagulans. Der NT-proBNP-Test ist für den Gebrauch zusammen mit dem Nexus IB10 Analysegerät vorgesehen und liefert innerhalb von 20 Minuten quantitative Ergebnisse. Der Test ist ausschließlich für den professionellen Gebrauch vorgesehen und kann im Zentrallabor von Krankenhäusern und...

 Open the catalog to page 10
IB10 sphingotest® NT-proBNP-11

ERFORDERLICHE, JEDOCH NICHT BEREITGESTELLTE MATERIALIEN/GERATE 1. Nexus IB10 Analysegerat - Modell Nr. BCA-IB10. 2. Handelsubliche NT-proBNP-Kontrollen zur externen Qualitatskontrolle (QC). Wenden Sie sich an den Handler in Ihrem Bereich, um empfohlene externe QC-Materialien oder damit verbundene technische Hilfe zu erhalten. 3. Kalibrierte, wiederverwendbare feste oder variable Volumenpipetten, die auBerst prazise und genau 500 pl Vollblut oder Plasma abgeben konnen. 4. Einweg-Pipettenspitzen zur Aufnahme und Abgabe von 500 pl Vollblut oder Plasma. • Gebrauchsanweisung genau beachten. • Stellen...

 Open the catalog to page 11
IB10 sphingotest® NT-proBNP-12

VERFAHREN Nexus IB10 Analysegerät Lesen Sie die Gebrauchsanweisung des Nexus IB10 Analysegeräts Hinweise zu Installation, Einrichtung und die vollständige Gebrauchsanweisung finden Sie im Benutzerhandbuch des Nexus IB10 Analysegeräts. Der Bediener muss die Gebrauchsanweisung vor Gebrauch lesen, um sich mit dem korrekten Betrieb und den Qualitätskontrollverfahren vertraut zu machen. DURCHFÜHRUNG VON SYSTEMPRÜFUNG UND DISKKALIBRIERUNG Bei jedem Einschalten des Nexus IB10 Analysegeräts wird automatisch ein Selbsttest durchgeführt. Der QR-Code auf jeder Testdisk enthält Informationen für die Diskkalibrierung,...

 Open the catalog to page 12
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.